ストックスクリーナーアプリを入手
42.45
0.02%
-0.010
アフターアワーズ：
42.45
前日終値:
$42.46
開ける：
$42.83
24時間の取引高:
1.21M
Relative Volume:
0.52
時価総額：
$6.02B
収益：
$3.24B
当期純損益:
$304.90M
株価収益率:
20.41
EPS:
2.08
ネットキャッシュフロー:
$156.70M
1週間 パフォーマンス:
+0.64%
1か月 パフォーマンス:
+13.50%
6か月 パフォーマンス:
-28.93%
1年 パフォーマンス:
-31.34%
1日の値動き範囲:
$42.11
$42.95
1週間の範囲:
$40.71
$43.21
52週間の値動き範囲:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
BRKR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
42.45 | 6.02B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker acquires Austria based biocrates - MSN
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Bruker's New Mass Spectrometry Platform Achieves 40% Higher Detection Rate for Environmental Contaminants - Stock Titan
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker expands multiomics with biocrates acquisition By Investing.com - Investing.com Canada
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics - Quantisnow
Bruker unveils new mass spectrometer with enhanced sensitivity By Investing.com - Investing.com South Africa
Bruker (BRKR) Unveils Advanced Mass Spectrometer for 4D-Proteomics | BRKR Stock News - GuruFocus
Bruker unveils new mass spectrometer with enhanced sensitivity - Investing.com
Bruker (BRKR) Unveils Advanced Proteomics System at Industry Conference | BRKR Stock News - GuruFocus
Revolutionary Mass Spectrometer Breakthrough: Bruker's New System Detects Single Cell Proteins at Record Speed - Stock Titan
New Bruker LC System Delivers 50% Better Peptide Sensitivity in Proteomics | BRKR Stock News - Stock Titan
Zacks Research Has Optimistic Outlook of Bruker Q4 Earnings - Defense World
Bruker Leadership to Share Strategic Insights at Major Jefferies Healthcare Conference Next Week - Stock Titan
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer – Company Announcement - Financial Times
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Zacks Research Has Pessimistic Outlook of Bruker Q2 Earnings - Defense World
Bruker unveils new timsMetabo system for metabolomics By Investing.com - Investing.com India
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Breakthrough Mass Spectrometer Transforms Metabolomics Research with 4D Technology and AI Integration - Stock Titan
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale - Yahoo Finance
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker launches MOVE-T for dairy quality control By Investing.com - Investing.com South Africa
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Revolutionary MOVE-T System Transforms Dairy Quality Control: Bruker's New FT-NIR Analyzer Sets Industry Standard - Stock Titan
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Deutsche Bank AG Has $865,000 Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
Bruker Corp (BRKR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
| LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
| Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.19%
大文字化:
|
ボリューム (24 時間):